← Open Payments lookup

MICHAEL ZADAKIS: Open Payments

NPI 1407548845 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,444 in 36 payments from 13 companies in 2025. Trend: 2023 $916 · 2024 $981 · 2025 $1,444

Food & beverage: $1,444
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.3$369
Alkermes, Inc.6$315
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$167
ABBVIE INC.3$148
Janssen Pharmaceuticals, Inc5$128
Vanda Pharmaceuticals Inc.3$67
Teva Pharmaceuticals USA, Inc.2$66
E.R. Squibb & Sons, L.L.C.3$63
AngioDynamics, Inc.1$36
Indivior Inc.1$31

Products named: ABILIFY MAINTENA, ARISTADA, CAPLYTA, VRAYLAR, SPRAVATO, REXULTI, LYBALVI, FANAPT.

Industry payments across AZ — which companies pay providers there.